Preclinical assessment of viral vectored and protein vaccines targeting the Duffy-binding protein region II of Plasmodium vivax

• Main Authors: de Cassan S.C., Rushdi Shakri A., Llewellyn D., Elias S.C., Cho J.S., Goodman A.L., Jin J., Douglas A.D., Suwanarusk R., Nosten F.H., Rénia L., Russell B., Chitnis C.E., Draper S.J.
• Other Authors: MICROBIOLOGY AND IMMUNOLOGY
• Format: Article
• Published: 2020
• Subjects: Duffy binding protein; gamma interferon; malaria vaccine; plasmodium vivax duffy binding protein region 2 vaccine; thymidine kinase; tissue plasminogen activator; unclassified drug; virus vector; animal model; animal tissue; antibody response; Article; cell invasion; chimpanzee adenovirus serotype 63; controlled study; DNA virus; drug targeting; enzyme inhibition assay; enzyme linked immunosorbent assay; female; gel permeation chromatography; gene expression; human; Human adenovirus 5; immobilized metal affinity chromatography; immunofluorescence test; immunogenicity; immunohistochemistry; mouse; nonhuman; nucleotide sequence; Plasmodium vivax malaria; protein binding; rabbit; recombinant DNA technology; recurrent disease; serotype; ultraviolet spectrophotometry; vaccination
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/174143
• Institution: National University of Singapore

10.3389/fimmu.2015.00348